near-significantp = 0.03
Here, compared with placebo, we observed absolute decreases in average urinary putrescine, the direct product of ODC ( Figure 1 A), with DFMO treatment for all treatment groups, with significant or near-significant differences in the 500 (p = 0.03) and 1,000 mg/m 2 (p = 0.05) dosing groups.